\-\ Texto\\:\\ \ \(0\)\
\-\ other\\ than\\ complaining\\ of\\ pain\\,\\ the\\ patient\\ appeared\\ to\\ be\\ clinically\\ well\\.\\ his\\ abdomen\\ was\\ soft\\,\\ relatively\\ non\\-tender\\ to\\ palpation\\ without\\ \\ involuntary\\ guarding\\ or\\ rebound\\ tenderness\\.\\ \ \(0\)\
\-\ serum\\ lactate\\ mildly\\ elevated\\.\\ no\\ electrolyte\\ abnormality\\.\\ no\\ acute\\ decrease\\ in\\ hemoglobin\\ or\\ hematocrit\\.\ \(0\)\
\-\ due\\ to\\ concern\\ that\\ the\\ proximity\\ of\\ the\\ high\\ grade\\ av\\ fistula\\ would\\ prevent\\ concentration\\ of\\ chemical\\ thrombolytic\\ agents\\ in\\ the\\ thrombo\\-embolis\\ by\\ preferential\\ flow\\ of\\ blood\\ into\\ the\\ portal\\ venous\\ system\\,\\ endovascular\\ therapy\\ was\\ not\\ attempted\\.\ \(0\)\
\-\ instead\\,\\ the\\ high\\ grade\\ av\\ fistula\\ and\\ a\\ segment\\ of\\ associated\\ ischemic\\ bowel\\ were\\ resected\\.\\ given\\ that\\ the\\ rest\\ of\\ the\\ hollow\\ and\\ solid\\ organs\\ in\\ the\\ vascular\\ territories\\ of\\ the\\ celiac\\ and\\ sma\\ appeared\\ normal\\ during\\ surgery\\,\\ the\\ vascular\\ surgeon\\ opted\\ to\\ not\\ perform\\ thrombectomies\\.\ \(0\)\
\-\ axial\\ images\\ from\\ enhanced\\ ct\\ of\\ the\\ abdomen\\ demonstrate\\ thrombus\\ occluding\\ the\\ celiac\\ plexus\\ and\\ the\\ distal\\ superior\\ mesenteric\\ artery\\.\\ no\\ focal\\ bowel\\ wall\\ thickening\\,\\ pneumatosis\\ intestinalis\\,\\ venous\\ gas\\,\\ solid\\ organ\\ infarction\\ or\\ venous\\ thrombosis\\ was\\ seen\\.\\ angiography\\ confirmed\\ these\\ occlusions\\ and\\ diagnosed\\ an\\ unsuspected\\ high\\ grade\\ av\\ fistula\\ of\\ a\\ jejunal\\ artery\\ to\\ a\\ jejunal\\ vein\\.\\ the\\ etiology\\ of\\ this\\ fistula\\ remains\\ unknown\\.\ \(0\)\
\-\ acute\\ mesenteric\\ ischemia\ \(6\)\
\-\ occlusive\\ acute\\ mesenteric\\ ischemia\\:\\ \ \(0\)\
\-\ 1\\.\\ emboli\\ \\(atrial\\ fibrillation\\,\\ ventricular\\ aneurysm\\)\ \(0\)\
\-\ 2\\.\\ arterial\\ thrombosis\\ \\(atherosclerotic\\)\ \(0\)\
\-\ 3\\.\\ venous\\ thrombosis\\ \\(portal\\ hypertension\\,\\ pancreatitis\\,\\ tumor\\)\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ non\\-occlusive\\ ami\\:\ \(0\)\
\-\ 1\\.\\ hypoperfusion\ \(0\)\
\-\ 2\\.\\ hypovolemia\ \(0\)\
\-\ middle\\ aged\\ man\\ presents\\ with\\ acute\\ onset\\ abdominal\\ pain\\ which\\ is\\ \\"out\\ of\\ proportion\\"\\ to\\ physical\\ exam\\.\ \(0\)\
\-\ although\\ limited\\,\\ the\\ experience\\ with\\ endovascular\\ management\\ of\\ acute\\ mesenteric\\ ischemia\\ due\\ to\\ emboli\\ with\\ thrombolysis\\ is\\ growing\\.\\ at\\ our\\ institution\\,\\ a\\ combination\\ of\\ catheter\\ directed\\ intra\\-arterial\\ t\\-pa\\ \\(alteplase\\)\\ and\\ systemic\\ intravenous\\ heparin\\ is\\ administered\\ in\\ either\\ the\\ angiography\\ suite\\ or\\ the\\ intensive\\ care\\ unit\\ to\\ ensure\\ close\\ monitoring\\ for\\ bleeding\\ complications\\.\\ vascular\\ surgery\\ is\\ closely\\ involved\\ in\\ the\\ event\\ of\\ a\\ bleeding\\ complication\\ or\\ complication\\ of\\ ischemic\\ bowel\\.\ \(0\)\
\-\ fibrinogen\\ levels\\ are\\ used\\ to\\ adjust\\ t\\-pa\\ infusion\\ rate\\ and\\ ptt\\ levels\\ are\\ used\\ to\\ adjust\\ the\\ heparin\\ infusion\\ rate\\.\\ since\\ t\\-pa\\ and\\ herapin\\ have\\ a\\ synergistic\\ effect\\,\\ the\\ range\\ of\\ appropriate\\ ptt\\ levels\\ is\\ lower\\ than\\ for\\ typical\\ systemic\\ anticoagulation\\.\\ \\ also\\,\\ to\\ minimize\\ potential\\ bleeding\\,\\ fibrinogen\\ and\\ ptt\\ levels\\ are\\ drawn\\ off\\ of\\ the\\ flush\\ line\\ for\\ the\\ vascular\\ sheath\\.\ \(0\)\
\-\ typically\\,\\ progress\\ of\\ thrombolysis\\ is\\ assessed\\ every\\ 8\\ to\\ 12\\ hours\\ with\\ catheter\\ angiography\\ and\\,\\ if\\ necessary\\,\\ the\\ infusion\\ catheter\\ is\\ repositioned\\.\\ treatment\\ is\\ typically\\ stopped\\ after\\ 36\\ hours\\ at\\ which\\ time\\ the\\ risk\\ of\\ bleeding\\ complication\\ usually\\ outweighs\\ the\\ probability\\ that\\ a\\ yet\\ unlysed\\ clot\\ will\\ open\\ up\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ t\\-pa\\:\\ 0\\.04978649119547347\ \(0\)\
\-\ ptt\\:\\ 0\\.03898664323694656\ \(0\)\
\-\ adjust\\:\\ 0\\.03791620827512472\ \(0\)\
\-\ infusion\\:\\ 0\\.03610737160708579\ \(0\)\
\-\ fistula\\:\\ 0\\.03604770417791163\ \(0\)\
\-\ av\\:\\ 0\\.0347195562547184\ \(0\)\
\-\ mesenteric\\:\\ 0\\.03389523527540083\ \(0\)\
\-\ bleeding\\:\\ 0\\.031910304946803594\ \(0\)\
\-\ levels\\:\\ 0\\.030341947469006134\ \(0\)\
\-\ fibrinogen\\:\\ 0\\.030209715934358894\ \(0\)\
\-\ angiography\\:\\ 0\\.027701482883338437\ \(0\)\
\-\ complication\\:\\ 0\\.027035778133433722\ \(0\)\
\-\ venous\\:\\ 0\\.02668202682543767\ \(0\)\
\-\ jejunal\\:\\ 0\\.02656542406172576\ \(0\)\
\-\ catheter\\:\\ 0\\.026490246597768802\ \(0\)\
\-\ thrombolysis\\:\\ 0\\.025991095491297706\ \(0\)\
\-\ ischemia\\:\\ 0\\.025621492500051014\ \(0\)\
\-\ vascular\\:\\ 0\\.024101533487515668\ \(0\)\
\-\ thrombosis\\:\\ 0\\.02366467062679384\ \(0\)\
\-\ endovascular\\:\\ 0\\.02300981729534095\ \(0\)\
\-\ acute\\:\\ 0\\.022686874506521456\ \(0\)\
\-\ celiac\\:\\ 0\\.022624388655815418\ \(0\)\
\-\ heparin\\:\\ 0\\.022624388655815418\ \(0\)\
\-\ grade\\:\\ 0\\.020998947051296582\ \(0\)\
\-\ appeared\\:\\ 0\\.020028539099384197\ \(0\)\
\-\ emboli\\:\\ 0\\.01989618787931214\ \(0\)\
\-\ portal\\:\\ 0\\.019346366926581454\ \(0\)\
\-\ thrombo\\-embolis\\:\\ 0\\.01895810413756236\ \(0\)\
\-\ thrombectomies\\:\\ 0\\.01895810413756236\ \(0\)\
\-\ non\\-occlusive\\:\\ 0\\.01895810413756236\ \(0\)\
\-\ hypovolemia\\:\\ 0\\.01895810413756236\ \(0\)\
\-\ alteplase\\:\\ 0\\.01895810413756236\ \(0\)\
\-\ herapin\\:\\ 0\\.01895810413756236\ \(0\)\
\-\ unlysed\\:\\ 0\\.01895810413756236\ \(0\)\
\-\ ischemic\\:\\ 0\\.017899174511006345\ \(0\)\
\-\ systemic\\:\\ 0\\.017583357441953367\ \(0\)\
\-\ ami\\:\\ 0\\.017467465039583983\ \(0\)\
\-\ outweighs\\:\\ 0\\.017467465039583983\ \(0\)\
\-\ bowel\\:\\ 0\\.017290022792804897\ \(0\)\
\-\ intra\\-arterial\\:\\ 0\\.016595497065157824\ \(0\)\
\-\ synergistic\\:\\ 0\\.016595497065157824\ \(0\)\
\-\ preferential\\:\\ 0\\.015976825941605606\ \(0\)\
\-\ occlusions\\:\\ 0\\.015976825941605606\ \(0\)\
\-\ unsuspected\\:\\ 0\\.015976825941605606\ \(0\)\
\-\ hypoperfusion\\:\\ 0\\.015976825941605606\ \(0\)\
\-\ flush\\:\\ 0\\.015976825941605606\ \(0\)\
\-\ occluding\\:\\ 0\\.015496947336628812\ \(0\)\
\-\ repositioned\\:\\ 0\\.015496947336628812\ \(0\)\
\-\ high\\:\\ 0\\.015087393942431068\ \(0\)\
\-\ hollow\\:\\ 0\\.014773351128841258\ \(0\)\
\-\ solid\\:\\ 0\\.014659555494651094\ \(0\)\
\-\ minimize\\:\\ 0\\.01448618684362723\ \(0\)\
\-\ hours\\:\\ 0\\.014452461542403426\ \(0\)\
\-\ rate\\:\\ 0\\.014325683830003625\ \(0\)\
\-\ opted\\:\\ 0\\.014232889992753286\ \(0\)\
\-\ suite\\:\\ 0\\.014232889992753286\ \(0\)\
\-\ used\\:\\ 0\\.014099716804077254\ \(0\)\
\-\ territories\\:\\ 0\\.014006308238650435\ \(0\)\
\-\ proportion\\:\\ 0\\.014006308238650435\ \(0\)\
\-\ involuntary\\:\\ 0\\.013801340110038984\ \(0\)\
\-\ electrolyte\\:\\ 0\\.013801340110038984\ \(0\)\
\-\ thrombolytic\\:\\ 0\\.013801340110038984\ \(0\)\
\-\ occlusive\\:\\ 0\\.013801340110038984\ \(0\)\
\-\ typically\\:\\ 0\\.012973874277445042\ \(0\)\
\-\ lactate\\:\\ 0\\.012865172214860821\ \(0\)\
\-\ intensive\\:\\ 0\\.012865172214860821\ \(0\)\
\-\ probability\\:\\ 0\\.012865172214860821\ \(0\)\
\-\ assessed\\:\\ 0\\.012742250894774912\ \(0\)\
\-\ concentration\\:\\ 0\\.012625977300645286\ \(0\)\
\-\ intestinalis\\:\\ 0\\.012625977300645286\ \(0\)\
\-\ proximity\\:\\ 0\\.012515669140672057\ \(0\)\
\-\ sma\\:\\ 0\\.012123579771222692\ \(0\)\
\-\ aged\\:\\ 0\\.012123579771222692\ \(0\)\
\-\ 2\\.\\:\\ 0\\.011687931792689283\ \(0\)\
\-\ fibrillation\\:\\ 0\\.011643701166245898\ \(0\)\
\-\ stopped\\:\\ 0\\.011643701166245898\ \(0\)\
\-\ instead\\:\\ 0\\.011573185418239467\ \(0\)\
\-\ 1\\.\\:\\ 0\\.011480383510957422\ \(0\)\
\-\ pneumatosis\\:\\ 0\\.011374533116882444\ \(0\)\
\-\ chemical\\:\\ 0\\.011312194327907709\ \(0\)\
\-\ drawn\\:\\ 0\\.011312194327907709\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.011192689271660804\ \(0\)\
\-\ unit\\:\\ 0\\.011135338202666909\ \(0\)\
\-\ closely\\:\\ 0\\.011079476941584628\ \(0\)\
\-\ \\,\\:\\ 0\\.011061271494254754\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.01102503004269368\ \(0\)\
\-\ to\\:\\ 0\\.011021112475948032\ \(0\)\
\-\ directed\\:\\ 0\\.010971927650026216\ \(0\)\
\-\ artery\\:\\ 0\\.01094421501982021\ \(0\)\
\-\ abdomen\\:\\ 0\\.010887674249013749\ \(0\)\
\-\ hematocrit\\:\\ 0\\.010820061914082229\ \(0\)\
\-\ agents\\:\\ 0\\.01077173319181974\ \(0\)\
\-\ organ\\:\\ 0\\.01077173319181974\ \(0\)\
\-\ or\\:\\ 0\\.01076906181681406\ \(0\)\
\-\ clot\\:\\ 0\\.010724466725757857\ \(0\)\
\-\ ensure\\:\\ 0\\.01067821682205686\ \(0\)\
\-\ administered\\:\\ 0\\.010588598120120153\ \(0\)\
\-\ organs\\:\\ 0\\.010545151437716886\ \(0\)\
\-\ perform\\:\\ 0\\.010545151437716886\ \(0\)\
\-\ progress\\:\\ 0\\.010379643822370374\ \(0\)\
\-\ yet\\:\\ 0\\.010301433834906126\ \(0\)\
\-\ attempted\\:\\ 0\\.010263370228240748\ \(0\)\
\-\ growing\\:\\ 0\\.010153062068267523\ \(0\)\
\-\ monitoring\\:\\ 0\\.010153062068267523\ \(0\)\
\-\ event\\:\\ 0\\.010153062068267523\ \(0\)\
\-\ sheath\\:\\ 0\\.01011751518235094\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.01008254632026109\ \(0\)\
\-\ experience\\:\\ 0\\.01008254632026109\ \(0\)\
\-\ institution\\:\\ 0\\.010014269549692098\ \(0\)\
\-\ guarding\\:\\ 0\\.00994809393965607\ \(0\)\
\-\ due\\:\\ 0\\.009807643668614363\ \(0\)\
\-\ surgeon\\:\\ 0\\.00979105063854878\ \(0\)\
\-\ every\\:\\ 0\\.009760972698818158\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.009731309640469048\ \(0\)\
\-\ is\\:\\ 0\\.009673819843178076\ \(0\)\
\-\ than\\:\\ 0\\.009630317655562468\ \(0\)\
\-\ rebound\\:\\ 0\\.00961658710131788\ \(0\)\
\-\ remains\\:\\ 0\\.009561442089246187\ \(0\)\
\-\ that\\:\\ 0\\.009522456313282732\ \(0\)\
\-\ atrial\\:\\ 0\\.009404015413927273\ \(0\)\
\-\ thrombus\\:\\ 0\\.009281094093841362\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.009281094093841362\ \(0\)\
\-\ combination\\:\\ 0\\.009257331005268061\ \(0\)\
\-\ 36\\:\\ 0\\.009210578345834929\ \(0\)\
\-\ concern\\:\\ 0\\.009142301575265941\ \(0\)\
\-\ prevent\\:\\ 0\\.009120016011748635\ \(0\)\
\-\ intravenous\\:\\ 0\\.009120016011748635\ \(0\)\
\-\ resected\\:\\ 0\\.009097959022141777\ \(0\)\
\-\ complaining\\:\\ 0\\.008970166720054034\ \(0\)\
\-\ close\\:\\ 0\\.008970166720054034\ \(0\)\
\-\ plexus\\:\\ 0\\.008929202859902003\ \(0\)\
\-\ surgery\\:\\ 0\\.008924727158538816\ \(0\)\
\-\ serum\\:\\ 0\\.008869183960725495\ \(0\)\
\-\ potential\\:\\ 0\\.008849544211127058\ \(0\)\
\-\ gas\\:\\ 0\\.008753949022802684\ \(0\)\
\-\ our\\:\\ 0\\.008735329533032545\ \(0\)\
\-\ appropriate\\:\\ 0\\.008662422970289145\ \(0\)\
\-\ rest\\:\\ 0\\.008473808818850207\ \(0\)\
\-\ decrease\\:\\ 0\\.008409126119415201\ \(0\)\
\-\ off\\:\\ 0\\.008393254920925691\ \(0\)\
\-\ ventricular\\:\\ 0\\.008211411075704049\ \(0\)\
\-\ open\\:\\ 0\\.008168255026132417\ \(0\)\
\-\ necessary\\:\\ 0\\.008139958070051748\ \(0\)\
\-\ clinically\\:\\ 0\\.008057234885475842\ \(0\)\
\-\ arterial\\:\\ 0\\.008043751846736927\ \(0\)\
\-\ segment\\:\\ 0\\.008017036749965838\ \(0\)\
\-\ either\\:\\ 0\\.008003802630451045\ \(0\)\
\-\ relatively\\:\\ 0\\.007863361558606386\ \(0\)\
\-\ enhanced\\:\\ 0\\.007863361558606386\ \(0\)\
\-\ mildly\\:\\ 0\\.007826599336328321\ \(0\)\
\-\ etiology\\:\\ 0\\.007778540629463812\ \(0\)\
\-\ limited\\:\\ 0\\.007754908109946403\ \(0\)\
\-\ the\\:\\ 0\\.007730067531815636\ \(0\)\
\-\ involved\\:\\ 0\\.007708408187337444\ \(0\)\
\-\ line\\:\\ 0\\.007553147346037468\ \(0\)\
\-\ 12\\:\\ 0\\.007521286946499531\ \(0\)\
\-\ are\\:\\ 0\\.007515315306642591\ \(0\)\
\-\ infarction\\:\\ 0\\.007510770849092667\ \(0\)\
\-\ range\\:\\ 0\\.007398365626413619\ \(0\)\
\-\ typical\\:\\ 0\\.007368702568064511\ \(0\)\
\-\ complications\\:\\ 0\\.0072820920322839945\ \(0\)\
\-\ aneurysm\\:\\ 0\\.007263309924824307\ \(0\)\
\-\ hypertension\\:\\ 0\\.007244690435054168\ \(0\)\
\-\ system\\:\\ 0\\.007235440796560856\ \(0\)\
\-\ unknown\\:\\ 0\\.007171783872310767\ \(0\)\
\-\ management\\:\\ 0\\.00693447622248525\ \(0\)\
\-\ confirmed\\:\\ 0\\.006910536780831822\ \(0\)\
\-\ 8\\:\\ 0\\.006871220555374942\ \(0\)\
\-\ which\\:\\ 0\\.006860836934376554\ \(0\)\
\-\ abnormality\\:\\ 0\\.006779694502861403\ \(0\)\
\-\ diagnosed\\:\\ 0\\.006757408939344098\ \(0\)\
\-\ since\\:\\ 0\\.006750031444512293\ \(0\)\
\-\ middle\\:\\ 0\\.0067207719777256725\ \(0\)\
\-\ risk\\:\\ 0\\.00665635838141739\ \(0\)\
\-\ vein\\:\\ 0\\.00664931897207337\ \(0\)\
\-\ care\\:\\ 0\\.006628337950685489\ \(0\)\
\-\ would\\:\\ 0\\.006539713717036752\ \(0\)\
\-\ effect\\:\\ 0\\.006506576888320957\ \(0\)\
\-\ was\\:\\ 0\\.00637598401428185\ \(0\)\
\-\ given\\:\\ 0\\.006299815897884607\ \(0\)\
\-\ 3\\.\\:\\ 0\\.006287901531485435\ \(0\)\
\-\ elevated\\:\\ 0\\.006235088949159275\ \(0\)\
\-\ thickening\\:\\ 0\\.006229300149878176\ \(0\)\
\-\ \\(\\:\\ 0\\.006213864311775144\ \(0\)\
\-\ although\\:\\ 0\\.006206299528121728\ \(0\)\
\-\ \\)\\:\\ 0\\.006137958641834883\ \(0\)\
\-\ palpation\\:\\ 0\\.006133202323329144\ \(0\)\
\-\ flow\\:\\ 0\\.006073234143781755\ \(0\)\
\-\ out\\:\\ 0\\.006073234143781755\ \(0\)\
\-\ a\\:\\ 0\\.005970319597269267\ \(0\)\
\-\ superior\\:\\ 0\\.005868266015170304\ \(0\)\
\-\ onset\\:\\ 0\\.005800905862204624\ \(0\)\
\-\ will\\:\\ 0\\.00574942154490138\ \(0\)\
\-\ during\\:\\ 0\\.0056236758062877595\ \(0\)\
\-\ tenderness\\:\\ 0\\.005589058758885233\ \(0\)\
\-\ usually\\:\\ 0\\.0055804908685306645\ \(0\)\
\-\ no\\:\\ 0\\.0055512525851858195\ \(0\)\
\-\ wall\\:\\ 0\\.00532292283922311\ \(0\)\
\-\ not\\:\\ 0\\.005311048050502948\ \(0\)\
\-\ his\\:\\ 0\\.005296535543326736\ \(0\)\
\-\ focal\\:\\ 0\\.005248373342233123\ \(0\)\
\-\ axial\\:\\ 0\\.005244712851758863\ \(0\)\
\-\ time\\:\\ 0\\.00519054027363293\ \(0\)\
\-\ blood\\:\\ 0\\.005015937790342579\ \(0\)\
\-\ distal\\:\\ 0\\.004996298040744144\ \(0\)\
\-\ if\\:\\ 0\\.004986545018883087\ \(0\)\
\-\ at\\:\\ 0\\.00497962646379197\ \(0\)\
\-\ up\\:\\ 0\\.0049416067764606955\ \(0\)\
\-\ therapy\\:\\ 0\\.004913206013420673\ \(0\)\
\-\ \\:\\:\\ 0\\.004861397058024366\ \(0\)\
\-\ these\\:\\ 0\\.0047824617031351395\ \(0\)\
\-\ of\\:\\ 0\\.004760370355186624\ \(0\)\
\-\ for\\:\\ 0\\.00470392353963042\ \(0\)\
\-\ abdominal\\:\\ 0\\.004593374705638958\ \(0\)\
\-\ in\\:\\ 0\\.004531153012260806\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.004516419435767348\ \(0\)\
\-\ physical\\:\\ 0\\.004508613482970405\ \(0\)\
\-\ pain\\:\\ 0\\.004488637279702085\ \(0\)\
\-\ soft\\:\\ 0\\.0044751113204162364\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.0044295688214671895\ \(0\)\
\-\ into\\:\\ 0\\.004372744877332703\ \(0\)\
\-\ man\\:\\ 0\\.004346089985139783\ \(0\)\
\-\ associated\\:\\ 0\\.004336478627758498\ \(0\)\
\-\ without\\:\\ 0\\.004326910035178839\ \(0\)\
\-\ tumor\\:\\ 0\\.0042843705410985184\ \(0\)\
\-\ other\\:\\ 0\\.004235781825166556\ \(0\)\
\-\ demonstrate\\:\\ 0\\.004228929336200088\ \(0\)\
\-\ were\\:\\ 0\\.004172658788580476\ \(0\)\
\-\ well\\:\\ 0\\.0041571633397175295\ \(0\)\
\-\ lower\\:\\ 0\\.004133036708309382\ \(0\)\
\-\ exam\\:\\ 0\\.00403706223645062\ \(0\)\
\-\ have\\:\\ 0\\.003979436727666864\ \(0\)\
\-\ and\\:\\ 0\\.003871161413596096\ \(0\)\
\-\ after\\:\\ 0\\.003802153123890758\ \(0\)\
\-\ presents\\:\\ 0\\.0037540737537804856\ \(0\)\
\-\ treatment\\:\\ 0\\.0037196063647330904\ \(0\)\
\-\ seen\\:\\ 0\\.0036314572367047103\ \(0\)\
\-\ also\\:\\ 0\\.0036228378358497877\ \(0\)\
\-\ images\\:\\ 0\\.0035252986923642025\ \(0\)\
\-\ by\\:\\ 0\\.003059937426333064\ \(0\)\
\-\ normal\\:\\ 0\\.002880886999137852\ \(0\)\
\-\ be\\:\\ 0\\.002833885426546084\ \(0\)\
\-\ from\\:\\ 0\\.002723517662697231\ \(0\)\
\-\ ct\\:\\ 0\\.0025705454911656837\ \(0\)\
\-\ an\\:\\ 0\\.0025412147619026447\ \(0\)\
\-\ this\\:\\ 0\\.0020669617490626517\ \(0\)\
\-\ patient\\:\\ 0\\.0018421331847664258\ \(0\)\
\-\ \\.\\:\\ 0\\.0016032048560091865\ \(0\)\
\-\ with\\:\\ 0\\.001006487536257116\ \(0\)\
